Unusual Options Volume Report: 3 Stocks Moving After Earnings

Impact · against what's priced in

DraftKings faces a significant valuation reset as revenue misses and prediction market spending confirm the market's skepticism of its growth trajectory. TransMedics sees a positive catalyst as its beat suggests the higher-end growth scenarios the market previously ignored are possible. Omada Health suffers a bearish reaction despite growth, indicating the market's valuation bar for the company has risen.

DKNG−0.70

Challenges what's priced in

The price assumes